BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 33407505)

  • 1. Circ_ZFR contributes to the paclitaxel resistance and progression of non-small cell lung cancer by upregulating KPNA4 through sponging miR-195-5p.
    Li J; Fan R; Xiao H
    Cancer Cell Int; 2021 Jan; 21(1):15. PubMed ID: 33407505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circular RNA circ_0000376 promotes paclitaxel resistance and tumorigenesis of non-small cell lung cancer via positively modulating KPNA4 by sponging miR-1298-5p.
    Hu S; Zhang Q; Sun J; Xue J; Wang C
    Thorac Cancer; 2023 Aug; 14(22):2116-2126. PubMed ID: 37455373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circ_0011292 Enhances Paclitaxel Resistance in Non-Small Cell Lung Cancer by Regulating miR-379-5p/TRIM65 Axis.
    Guo C; Wang H; Jiang H; Qiao L; Wang X
    Cancer Biother Radiopharm; 2022 Mar; 37(2):84-95. PubMed ID: 32833503
    [No Abstract]   [Full Text] [Related]  

  • 4. Circ_0011292 knockdown mitigates progression and drug resistance in PTX-resistant non-small-cell lung cancer cells by regulating miR-433-3p/CHEK1 axis.
    Jin M; Zhang F; Li Q; Xu R; Liu Y; Zhang Y
    Thorac Cancer; 2022 May; 13(9):1276-1288. PubMed ID: 35348291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Circ-RNF111 contributes to paclitaxel resistance in breast cancer by elevating E2F3 expression via miR-140-5p.
    Zang H; Li Y; Zhang X; Huang G
    Thorac Cancer; 2020 Jul; 11(7):1891-1903. PubMed ID: 32445273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circular RNA hsa_circ_0008003 promotes the progression of non-small-cell lung cancer by sponging miR-548I and regulating KPNA4 expression.
    Yang W; Yao Y; Yang S; Ke Y
    Thorac Cancer; 2023 Feb; 14(6):544-554. PubMed ID: 36573325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking circ_0010235 suppresses acquired paclitaxel resistance of non-small cell lung cancer by sponging miR-512-5p to modulate FAM83F expression.
    Li Y; Ma Z; Luo M; Liang R
    Anticancer Drugs; 2022 Nov; 33(10):1024-1034. PubMed ID: 36206095
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circ_PIP5K1A regulates cisplatin resistance and malignant progression in non-small cell lung cancer cells and xenograft murine model via depending on miR-493-5p/ROCK1 axis.
    Feng N; Guo Z; Wu X; Tian Y; Li Y; Geng Y; Yu Y
    Respir Res; 2021 Sep; 22(1):248. PubMed ID: 34537072
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hsa_circ_0003489 Drives PTX Resistance of Human NSCLC Cells Through Modulating miR-98-5p/IGF2.
    Xia S; Wang C
    Pharmgenomics Pers Med; 2023; 16():805-815. PubMed ID: 37692338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. circ_ZFR Is Linked to Paclitaxel Resistance in Cervical Cancer via miR-944 Sponging and IL-10 Upregulation.
    Long X; Zheng M; Yang Y; Chen Y; Zhang X; Zhang H
    Anal Cell Pathol (Amst); 2022; 2022():4807287. PubMed ID: 35127342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hsa_circ_0092887 targeting miR-490-5p/UBE2T promotes paclitaxel resistance in non-small cell lung cancer.
    Wang L; Zhang Z; Tian H
    J Clin Lab Anal; 2023 Jan; 37(1):e24781. PubMed ID: 36550019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Circ_0069094 regulates malignant phenotype and paclitaxel resistance in breast cancer cells via targeting the miR-136-5p/YWHAZ axis.
    Kong Z; Han Q; Zhu B; Wan L; Feng E
    Thorac Cancer; 2023 Jul; 14(19):1831-1842. PubMed ID: 37192740
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circ_0072088 promotes the development of non-small cell lung cancer via the miR-377-5p/NOVA2 axis.
    Tan Z; Cao F; Jia B; Xia L
    Thorac Cancer; 2020 Aug; 11(8):2224-2236. PubMed ID: 32524752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ginsenoside Rg3 inhibits osteosarcoma progression by reducing circ_0003074 expression in a miR-516b-5p/KPNA4-dependent manner.
    Wang T; Zhang C; Wang S
    J Orthop Surg Res; 2021 Dec; 16(1):724. PubMed ID: 34930332
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circ_0074027 Contributes to Non-Small Cell Lung Cancer Progression by Upregulating
    Yu C; Ying J; Yu K; Shen W; Jiang M
    Cancer Biother Radiopharm; 2022 Mar; 37(2):73-83. PubMed ID: 32580576
    [No Abstract]   [Full Text] [Related]  

  • 16. Downregulation of circ_PLXND1 inhibits tumorigenesis of non-small cell lung carcinoma via miR-1287-5p/ERBB3 axis.
    Wu J; Liu C; Yu G
    Thorac Cancer; 2023 Jun; 14(17):1543-1555. PubMed ID: 37073425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of circ_CELSR1 facilitates paclitaxel resistance of ovarian cancer by regulating miR-149-5p/SIK2 axis.
    Wei S; Qi L; Wang L
    Anticancer Drugs; 2021 Jun; 32(5):496-507. PubMed ID: 33735118
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circ_0006528 Contributes to Paclitaxel Resistance of Breast Cancer Cells by Regulating miR-1299/CDK8 Axis.
    Liu G; Zhang Z; Song Q; Guo Y; Bao P; Shui H
    Onco Targets Ther; 2020; 13():9497-9511. PubMed ID: 33061434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Circ_0001402 knockdown suppresses the chemoresistance and development of DDP-resistant cutaneous squamous cell carcinoma cells by functioning as a ceRNA for miR-625-5p.
    Li M; Luo M; Liu P; Wang R; Jing H
    Exp Dermatol; 2023 Apr; 32(4):529-541. PubMed ID: 36635223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hsa_circRNA_0017620 regulated cell progression of non-small-cell lung cancer via miR-520a-5p/KRT5 axis.
    Chen S; Hong K; Zhou L; Ran R; Huang J; Zheng Y; Xing M; Cai Y
    J Clin Lab Anal; 2022 Apr; 36(4):e24347. PubMed ID: 35302673
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.